Eastman Chemical (NYSE: EMN) reported Q3 EPS of $2.34, $0.05 better than the analyst estimate of $2.29. Revenue for the quarter came in at $2.55 billion versus the consensus estimate of $2.56 billion.

Outlook

Commenting on the outlook for full-year 2018, Costa said: “During the first nine months of the year, we delivered a 13 percent year-over-year increase in adjusted earnings per share. This performance continues to be driven by strong volume growth in the specialty segments leveraging our innovation-driven growth model, as well as continued disciplined cost management, use of our robust free cash flow and a lower effective tax rate. Despite facing challenges in the global economy, we remain confident in our expectations for adjusted 2018 EPS growth to be between 10-14 percent.”

For earnings history and earnings-related data on Eastman Chemical (EMN) click here.